Febuskip 40 contains Febuxostat 40 mg, a urate-lowering medicine used for the long-term management of hyperuricemia associated with gout. Febuxostat works by inhibiting xanthine oxidase, an enzyme involved in the production of uric acid, thereby helping lower uric-acid levels in the blood. Key benefits - Helps lower elevated uric acid levels - Helps prevent the formation and accumulation of urate crystals - Used for long-term management of gout and hyperuricemia - Helps reduce the risk of recurrent gout problems when uric acid is maintained at the appropriate target level.

Enzoskip-D is a combination tablet containing Trypsin, Bromelain, Rutoside Trihydrate and Diclofenac Sodium. It is formulated to help manage pain, inflammation and swelling, particularly where these symptoms are associated with injuries, musculoskeletal conditions or post-surgical inflammation. Key benefits - Helps reduce pain and inflammation - Helps reduce swelling and oedema - Supports management of soft-tissue injuries and trauma - May be prescribed for musculoskeletal and joint-related pain - Can be used in post-operative pain and inflammation, under medical supervision.

Drotazer-MF is a combination tablet containing Drotaverine Hydrochloride and Mefenamic Acid. It combines an antispasmodic action with analgesic and anti-inflammatory action, helping relieve pain associated with smooth-muscle spasms. Key benefits - Helps relieve abdominal cramps and spasmodic pain - Provides relief from menstrual cramps (dysmenorrhea) - Helps manage renal, biliary and intestinal colic - Drotaverine helps relax smooth muscles - Mefenamic Acid helps reduce pain and inflammation